USRE45922E1 - Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation - Google Patents
Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation Download PDFInfo
- Publication number
- USRE45922E1 USRE45922E1 US13/872,037 US201313872037A USRE45922E US RE45922 E1 USRE45922 E1 US RE45922E1 US 201313872037 A US201313872037 A US 201313872037A US RE45922 E USRE45922 E US RE45922E
- Authority
- US
- United States
- Prior art keywords
- pulse
- patient
- output signal
- individual
- sensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime, expires
Links
- 238000012545 processing Methods 0.000 title claims abstract description 32
- 230000000747 cardiac effect Effects 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 31
- 230000006835 compression Effects 0.000 claims abstract description 29
- 238000007906 compression Methods 0.000 claims abstract description 29
- 230000033001 locomotion Effects 0.000 claims abstract description 21
- 230000008569 process Effects 0.000 claims abstract description 17
- 239000008280 blood Substances 0.000 claims description 18
- 210000004369 blood Anatomy 0.000 claims description 18
- 230000001419 dependent effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 description 32
- 238000002680 cardiopulmonary resuscitation Methods 0.000 description 26
- 230000003287 optical effect Effects 0.000 description 24
- 210000002216 heart Anatomy 0.000 description 21
- 230000035939 shock Effects 0.000 description 19
- 210000000038 chest Anatomy 0.000 description 14
- 230000000541 pulsatile effect Effects 0.000 description 11
- 230000033764 rhythmic process Effects 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 208000010496 Heart Arrest Diseases 0.000 description 5
- 238000002106 pulse oximetry Methods 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 238000010009 beating Methods 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 210000000624 ear auricle Anatomy 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 210000000492 nasalseptum Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 210000001562 sternum Anatomy 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 208000003663 ventricular fibrillation Diseases 0.000 description 2
- 206010007687 Carotid artery stenosis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000002230 Diabetic coma Diseases 0.000 description 1
- 206010019332 Heat exhaustion Diseases 0.000 description 1
- 206010072563 Peripheral artery stenosis Diseases 0.000 description 1
- 206010058151 Pulseless electrical activity Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 208000006170 carotid stenosis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 210000002321 radial artery Anatomy 0.000 description 1
- 230000034225 regulation of ventricular cardiomyocyte membrane depolarization Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H31/00—Artificial respiration by a force applied to the chest; Heart stimulation, e.g. heart massage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3904—External heart defibrillators [EHD]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3904—External heart defibrillators [EHD]
- A61N1/39044—External heart defibrillators [EHD] in combination with cardiopulmonary resuscitation [CPR] therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3925—Monitoring; Protecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H31/00—Artificial respiration by a force applied to the chest; Heart stimulation, e.g. heart massage
- A61H31/004—Heart stimulation
- A61H31/005—Heart stimulation with feedback for the user
Definitions
- This invention relates to pulse sensors and methods of using pulse sensors in conjunction with external defibrillators.
- the pulse is a very important parameter that is used to aid users of automated external defibrillators in determining whether or not to administer a defibrillation shock to and/or to perform cardiopulmonary resuscitation (CPR) on a victim who appears to be in cardiac arrest.
- CPR cardiopulmonary resuscitation
- Such a victim may actually be in need of cardiac resuscitation (including defibrillation and/or CPR), or may be suffering from a condition for which such treatment would be unsuitable, e.g., a stroke, seizure, diabetic coma, or heat exhaustion. It is very important to the safety of the victim that the presence or absence of a pulse be determined quickly and accurately.
- Another parameter that is used in determining whether to administer a defibrillation shock is an ECG analysis of the victim's heart rhythm that is provided by the automated external defibrillator. Based on the ECG analysis, many automated defibrillators will provide the user with a message indicating whether a shock should be administered (i.e., whether or not ventricular fibrillation is present).
- the ECG analysis systems in most commercially available automated external defibrillators display only two options to the user: “Shock Advised” or “No Shock Advised.”
- shock Advised When “Shock Advised” is output, this means that the patient is in ventricular fibrillation or wide complex ventricular tachycardia above 150 BPM, conditions which are effectively treated by defibrillation.
- No Shock Advised When “No Shock Advised” is output, this means that the patient's heart rhythm is not treatable by defibrillation therapy.
- CPR cardiopulmonary resuscitation
- the caregiver does not know whether this result is caused by a normal heart rhythm, an abnormal but perfusing heart rhythm (i.e., the patient was never in cardiac arrest or the last shock treatment returned the patient's heart rhythm to normal), or a grossly abnormal (non-perfusing) ECG rhythm requiring CPR treatment. Because of this uncertainty, the normal medical protocol when “No Shock Advised” is output is to check the patient for a pulse and if no pulse is detected to start CPR. If a pulse is detected, then the patient's heart is effectively pumping blood and neither CPR nor defibrillation is warranted.
- CPR should be started immediately; if a pulse is present, then CPR should not be administered. Because CPR, even if properly administered, can result in broken ribs or other injury to the victim, it is undesirable to administer CPR if it is not actually necessary. Thus, it is again vitally important that an accurate determination of the presence or absence of a pulse be made by the caregiver.
- Optical sensors have been used in pulse detection.
- pulse detectors of the type used for measuring heart rate during exercise typically rely on reflectance or transmission of an infrared light beam.
- Blood pulsing in the user's capillaries produces a corresponding variation in the absorption of light by capillaries, and that variation produces a pulsation in the output of an optical sensor.
- Optical sensors are also widely used in pulse oximetry, in which a measurement is made of the percentage of hemoglobin saturated with oxygen.
- An optical plethysmographic probe attached to the patient's finger or ear lobe generates light at two wavelengths (e.g., 650 nm and 805 nm). The light is partially absorbed by hemoglobin, by amounts that differ depending on whether or not the hemoglobin is saturated with oxygen.
- a pulse oximetry device can compute the proportion of hemoglobin that is saturated (oxygenated).
- Acoustic sensors have also been applied to pulse detection.
- the acoustic sensor is configured to detect sounds characteristic of a beating heart (e.g., the action of a heart valve).
- a beating heart e.g., the action of a heart valve.
- Some acoustic sensors used for pulse detection are based on piezoelectric devices.
- the piezoelectric device detects motion of the surface of the body resulting from the pulse (e.g., motion resulting from blood flowing in a blood vessel beneath the sensor).
- the invention features a cardiac resuscitation device, comprising a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, wherein the pulse sensor has a pulse sensor output signal as its output, an accelerometer configured to detect chest movements of the patient during chest compressions, wherein the accelerometer has an accelerometer output signal as its output, and memory and processing circuits configured to process the pulse sensor output signal and accelerometer output signal to monitor the effect that chest compressions have on the patient's pulse.
- the memory and processing circuits may be configured to process the pulse sensor output signal in conjunction with the accelerometer output signal to provide information to the user of the device to improve delivery of CPR to the patient.
- the memory and processing circuits may be configured to process the pulse sensor output signal in conjunction with the accelerometer output signal to determine if chest compressions actually result in the movement of blood thus resulting in a pulse.
- the device may comprise a defibrillator for delivering a defibrillation waveform to the patient and chest electrodes for detecting at least one ECG signal on the patient and for delivering a defibrillation waveform to the patient.
- the memory and processing circuits may be further configured to analyze the pulse sensor output signal in conjunction with the ECG signal to determine whether the patient has a pulse. The pulse rate of the pulse signal may be compared to the pulse rate of the ECG signal.
- the memory and processing circuits may be configured to process the accelerometer output signal to determine the rate and depth of delivered chest compressions.
- the memory and processing circuits may be configured to process the pulse sensor output signal to determine the magnitude and frequency of the patient's pulse.
- a decision whether to deliver a defibrillation waveform to the patient may be based in part on whether processing of the ECG and pulse sensor output signals determines that the patient has a pulse.
- the defibrillator may comprise an automatic external defibrillator (AED).
- AED automatic external defibrillator
- the invention may further comprise the capability to provide the user with prompts for performing CPR, and wherein the prompts may be dependent at least in part on whether the processing of the pulse signal determines that the patient has a pulse.
- a determination of whether the patient has a pulse may be undertaken after delivery of the defibrillation waveform, and the user may be informed of the outcome of the determination.
- the memory and processor circuits may be further configured to make a determination whether to administer CPR to the patient and the determination may be based at least in part on whether it is determined that the patient has a pulse.
- the memory and processing circuits may be further configured to use the pulse sensor output signal to determine the efficacy of CPR treatment of the patient.
- an external defibrillator can be configured to determine whether a patient has a pulse by analyzing the output of a pulse sensor in conjunction with the patient's ECG signal to determine whether a pulse is present.
- the invention features applying electrodes to the chest of the patient, detecting at least one ECG signal from electrodes, applying a pulse sensor (of varying kinds) to the patient, detecting a pulse signal from the pulse sensor, and analyzing the pulse signal in conjunction with the ECG signal to determine whether the patient has a pulse.
- the pulse rate of the pulse signal may be compared to the pulse rate of the ECG signal.
- the pulse signal may be processed to isolate the pulsatile component of the signal.
- the pulse signal may be examined for a peak during a window initiated at the occurrence of an R-wave in the ECG signal.
- a comparison may be made of the energy in discrete frequency bands of the pulse and the ECG signals.
- a peak frequency corresponding to the peak of one of the pulse and ECG signals may be determined, and the other of the pulse and ECG signals may be examined for a peak within a frequency band surrounding the peak frequency.
- a frequency domain transformation of the pulse signal may be processed.
- the frequency domain transformations of the pulse and ECG signal may be processed.
- a decision whether to deliver a defibrillation waveform to the patient may be based in part on whether processing of the ECG and pulse signals determines that the patient has a pulse.
- the defibrillator may be an automatic external defibrillator (AED).
- the implementation may include the capability to provide the user with prompts for performing CPR, wherein the prompts are dependent at least in part on whether the processing of the pulse signal determines that the patient has a pulse.
- a determination of whether the patient has a pulse may be undertaken after delivery of the defibrillation waveform, and the user may be informed of the outcome of the determination.
- the pulse sensor e.g., an optical plethysmographic sensor
- the pulse sensor may be supported on the same substrate.
- the wires connected to the pulse sensor may be bundled with wires connected to the defibrillation electrodes to form a combined bundle of wires extending from the defibrillator to the electrodes and sensor.
- the pulse sensor may be mechanically separate from the defibrillation electrodes.
- the sensor may be configured to be attached to the forehead of the patient to the ear lobe, to the nasal septum, to the nasal bridge, or to the finger.
- the sensor may be configured so that its output may also be used for pulse oximetry, or it may be configured so that its output is not useful for pulse oximetry.
- Determining whether the patient has a pulse may include determining whether the pulse, if present, is correlated with the R-wave of the patient's heart rhythm. A determination whether to administer CPR to the patient may be based on whether it is determined that the patient has a pulse.
- the pulse sensor may be to determine the efficacy of CPR treatment of the patient. Analyzing the pulse signal in conjunction with the ECG signal may comprise analyzing whether there is a correlation between the two signals indicative of the presence of a pulse.
- the pulse sensor may include a non-optical sensor.
- the pulse sensor may be an acoustic (heart sounds) sensor.
- the pulse sensor may include an ultrasonic blood flow sensor.
- the pulse sensor may include a pressure sensor on a limb-compressing pneumatic cuff.
- the pulse sensor may include at least one mechanical or ultrasonic sensor (e.g., a piezoelectric sensor) configured to detect arterial wall motion caused by blood flow in an artery.
- the pulse sensor may include one or more sensors for measuring body impedance variation from blood flow.
- Implementations of the invention have many and various advantages. They can make it possible to perform a quick and accurate determination of the appropriate treatment (defibrillation, CPR, or no cardiac-related treatment) for a patient who appears to be suffering from cardiac arrest. They can provide an accurate determination of the presence or absence of a pulse in a patient, even under adverse conditions, thus significantly reducing the risk that an inappropriate and even dangerous treatment will be given erroneously. The accurate pulse determination thus provided relieves the uncertainty experienced by caregivers in the circumstances discussed above, and thus increases the likelihood of the patient receiving prompt, safe and effective treatment. For example, a pulse sensor can be used to determine whether CPR is necessary, in the event that an automated defibrillator indicates that it is not appropriate to shock a patient who appears to be suffering from cardiac arrest.
- the invention provides an optical sensor without the complexity of pulse oximetry, in which two optical measurements, one at each of two wavelengths, are made, and complex signal processing is performed to estimate blood oxygen saturation from the two measurements.
- FIG. 1 is a diagrammatic, perspective view of an electrode pad with built-in pulse sensor applied to the chest of patient.
- FIGS. 2A-2F are diagrammatic views of other possible pulse sensors applied to the patient.
- FIG. 3A shows an unprocessed pulse signal from a pulse sensor.
- FIG. 3B shows a filtered pulse signal, preconditioned for beat detection.
- FIG. 4 is a block diagram of an algorithm used in one implementation of the invention.
- FIG. 5 illustrates how an ECG signal is used in conjunction with the pulse signal from the pulse sensor.
- FIG. 6 is a block diagram of an algorithm for using an ECG signal in conjunction with the pulse signal.
- FIGS. 7 and 8 illustrate other implementations of the invention, in which the frequency transforms of the ECG and pulse signals are compared.
- FIG. 9 is a table summarizing a decision algorithm used in one implementation of the invention.
- FIG. 10A is a diagrammatic view of a transmittance optical sensor.
- FIG. 10B is a diagrammatic view of a reflectance optical sensor.
- FIG. 1 shows a defibrillator 10 connected to a patient 20 .
- Cable 12 connects the defibrillator to an electrode assembly 14 , which supports two chest electrodes 16 , 18 , an accelerometer 20 (for measuring chest compression), and a pulse sensor 22 (e.g., an optical plethysmographic sensor). All wiring for the electrodes, accelerometer, and pulse sensor are bundled together in cable 12 .
- FIGS. 2A-2F show alternative locations for the pulse sensor in the event the sensor is an optical plethysmographic sensor 22 (some of the same locations may be useful with other types of pulse sensors): anywhere on the forehead, the bridge of the nose, the septum of the nose, the ear lobe, the sternum above the accelerometer, and on any of the fingers or thumb. All of the sensors shown are commercially available, except the nasal septum and sternum sensor.
- the nasal septum sensor would be a transmittance sensor (e.g., as shown in FIG. 10A ), similar to that available for the ear lobe.
- the sternum sensor would be a reflectance sensor (e.g., as shown in FIG. 10B ).
- the optical plethysmographic sensor 22 detects transmitted or reflected light, and provides a pulse signal 34 , which represents a parameter correlated with the patient's pulse.
- the pulse signal 34 would be an optical signal representing the brightness of light transmitted through or reflected from a portion of the body through which blood capillaries extend.
- the term “pulse signal” is simply a shorthand for an electrical signal representative of a parameter correlated with the pulse of the patient.
- the pulse signal could be the light sensed by the optical receiver. If the patient has a pulse, there will generally be a pulsing variation in the pulse signal. In the case of an optical sensor, the variation will be in the absorption of light by the blood capillaries.
- a variety of signal processing techniques may be used to process the pulse signal to determine whether a pulse is present or absent. Several possibilities are described below. These may be used alone or in combination.
- One processing technique is to process the pulse signal 34 to isolate any pulsatile component.
- FIG. 3 shows a typical pulse signal 34 that would be detected when a pulse is present.
- a time domain analysis can be performed on the pulse signal to determine whether it contains a pulsatile component.
- the non-pulsatile component can be estimated as the mean of the pulse signal, and variation from the mean can be analyzed for the presence of a pulsatile component indicative of a pulse.
- the frequency and strength of the pulsatile component i.e., the variation from the mean
- the pulse signal may be filtered so that pulses in the waveform are enhanced and then detected with a beat detection algorithm (e.g., the algorithm conventionally utilized for ECG R-wave detection).
- the filtering may include a high pass filter, a low pass filter, and also a notch filter to remove line noise if necessary.
- the high pass filter with a ⁇ 3 dB cutoff frequency near 0.5 Hz removes any DC component, thus enhancing any existing pulsatile component.
- the low pass filter, with a ⁇ 3 dB point in the range of 5-15 Hz removes some signal components unrelated to patients' pulse (i.e., noise).
- FIG. 3A illustrates a raw pulse signal
- FIG. 3B shows a filtered, preconditioned pulse signal ready to be processed by a beat detection algorithm.
- the beat detection algorithm of FIG. 4 may be applied to the preconditioned pulse signal of FIG. 3B .
- the beat detection algorithm is intended to identify individual pulses within the pulse waveform.
- the arrows at the bottom of FIG. 3B indicate detection of a beat by the algorithm.
- Time intervals may then be computed between any two successive pulse detections. These time intervals, derived from the pulse waveform, may then by analyzed to determine the likelihood of a pulse. A moving average of these intervals may also be computed and updated as new intervals are measured. If the average interval is within a range (e.g. 35-185 beats/minute), then a pulse might be declared present.
- Another processing technique is to use both a pulse signal from the pulse sensor and an ECG signal from the electrodes.
- both the pulse signal and the ECG signal will exhibit periodicity when a pulse is present, because a true pulse originates from a mechanically beating heart, and thus the same periodicity observed on the pulse signal should be present on the ECG signal when the heart is beating.
- a periodic ECG signal is not always indicative of a pulse, and thus should only be used to verify (or in combination with) periodicity detected in the pulse signal.
- FIG. 5 shows an ECG signal 38 in the upper half of the figure and the filtered, pulsatile component 44 of the pulse signal in the lower half of the figure.
- FIG. 6 shows the algorithm followed in processing the signals.
- an ECG R-wave (ventricular depolarization) 40 Upon detecting ( 50 in FIG. 6 ) an ECG R-wave (ventricular depolarization) 40 a time window 42 is initiated ( 52 in FIG. 6 ).
- the duration of a time window may change as a function of the previous ECG cycle length or current average ECG cycle length.
- This variable window length is intended to shorten for shorter cycle lengths (high heart rates) and lengthen for longer cycle lengths (lower heart rates).
- the pulsatile component 44 of the pulse signal is analyzed for a corresponding pulse ( 54 in FIG. 6 ).
- the pulse signal is not analyzed outside of this time window, thereby reducing the number of false detections on the pulse signal.
- the entire pulse signal is analyzed and pulse detects outside of an R-wave initiated time window are ignored. Detection of a pulse on the pulse signal within the time window could be sufficient to conclude that a pulse is present. Greater confidence that a pulse is present can be had using a confidence index that is increased each time a pulse is detected in the pulse signal during the prescribed time window following an R-wave.
- all of the pulse pulses, except the seventh pulse 46 are detected and considered as valid detects since they are within time windows initiated by R-wave detections on the ECG signal.
- the portion of the pulse waveform comprising the seventh pulse 46 is either not analyzed or detected and ignored since it is outside of an pulse detect time window.
- One possible confidence index would be the percentage of instances in which a pulse is detected in a window following detection of an R-wave. If the confidence index exceeds an empirically determined threshold, the existence of a pulse is declared. Otherwise a pulse is considered to be absent.
- a simpler technique is to determine the pulse rate of each of the ECG and pulse signals, and simply compare the two pulse rates. If the difference between the two rates is within a range (e.g., 1-5 beats/minute), the existence of a pulse is declared. This technique may be used in conjunction with the pulse windowing scheme to minimize the number of false positive detections on the pulse signal. If the implementation does not employ a method (e.g., windowing scheme) to minimize false positive detections on the pulse signal, then the comparison between pulse and ECG derived pulse rates may be modified. In this case the absence of a pulse would be declared if the pulse rate is less than the ECG rate. This modification takes into consideration that the pulse rate may be higher than the ECG rate due to false pulse detections, and such a condition may be indicative of a pulse despite the difference between the two rates being outside of a range.
- a range e.g. 1-5 beats/minute
- Another technique is to compare band-limited versions of the ECG and pulse signals.
- the signals can be band limited over a range of likely pulse frequencies (e.g., 0.5-5 Hz).
- the band-limited signals are compared to determine if a pulse or peak frequency of the pulse signal compares well with a pulse or peak frequency of the ECG signal. If the two compare well, the existence of a patient pulse is supported. Comparisons can be made using several different quantitative techniques. Cross correlation (convolution) of the two filtered waveforms is one technique that can be used to quantify the comparison of the two waveforms.
- FIG. 7 One technique for comparing the peak frequencies of the two signals is shown in FIG. 7 .
- Each of the ECG and pulse signals is transformed into a frequency domain using, e.g., an FFT, wavelet, or other transform.
- the frequency peak of the transformed pulse signal is then compared with the ECG derived heart rate or peak frequency.
- An association between the two frequency peaks supports the existence of a pulse.
- a quantitative technique for determining how well the two frequency peaks compare is suggested in FIG. 7 .
- the energy levels in discrete frequency bands are compared, e.g., the a-b band 60 in the ECG transform is compared to the a-b band 62 in the pulse signal transform.
- the peak frequencies can also be compared by examining one signal for a peak located within a predetermined frequency band centered on the peak frequency of the other signal.
- the peak ECG frequency 70 could be measured and updated at regular intervals (which could be constant or variable as a function of heart rate), with the measurement being done either in the time domain or in a transformed frequency domain.
- the pulse signal 74 would then be examined for a corresponding peak frequency within a band 72 centered on the continuously updated peak ECG frequency (e.g., using an adaptive filter).
- the existence of a peak on the pulse signal within the ECG determined band supports the existence of a pulse.
- the peak in the pulse signal is outside the band, thus suggesting that a pulse is not present.
- the autocorrelation of the ECG signal can also be compared with the autocorrelation of the pulse signal. Comparing autocorrelation signals improves the signal to noise ratio and may be particularly useful if the periodic component of the signals is small.
- the two autocorrelation signals may be compared using a cross-coeerlation. The comparison determines if the periodicity of the two autocorrelated signals are similar. Similar periodicities support the existence of a pulse.
- the addition of a pulse detection system adds significant improvements to automatic and semi-automatic external defibrillators.
- the addition of a pulse detection system will reduce the number of inappropriate shock advisements. Particularly in cases where patients have a pulse, but have been incorrectly classified by the ECG analysis algorithm as having a shockable rhythm. As shown in the table of FIG. 9 , the addition of the pulse detection system will override the shock advisement from the ECG analysis algorithm thereby appropriately inhibiting defibrillation therapy.
- the addition of a pulse detection system will also enable the defibrillator to advise the rescuer when CPR is appropriate and inappropriate.
- the defibrillator may indicate to the rescuer that CPR should be administered. Conversely, detection of a pulse by the pulse detection system may be used to indicate to the rescuer that CPR is no longer necessary.
- the pulse detection system may also be used to improve the defibrillator system by providing feedback to the rescuer during the administration of CPR.
- the pulse detection system may be utilized to monitor the effect that chest compressions have on a patients pulse.
- the detected magnitude and frequency of a pulse by the pulse detection system may be used independently or in conjunction with accelerometer data to aid the rescuer in delivering optimal CPR to the victim.
- an accelerometer may be used to measure the rate and depth of delivered chest compressions
- a pulse detection system may be used to determine if these chest compressions actually result in the movement of blood thus resulting in a pulse.
- the senor could be optical or non-optical. It could include an acoustic sensor (e.g., amplified stethoscope signals) for detecting heart sounds characteristic of a beating heart. It could include a sensor capable of mechanical or ultrasonic measurement (e.g., piezoelectric) of arterial wall motion—e.g., in locations such as the neck (carotid arteries), arms (radial and brachial arteries), and legs (femoral artery) where the arteries are relatively close to the surface. It could include an ultrasonic measurement of blood flow (e.g., such as the ultrasonic blood flow detectors used to detect carotid and/or femoral artery stenosis).
- an ultrasonic measurement of blood flow e.g., such as the ultrasonic blood flow detectors used to detect carotid and/or femoral artery stenosis.
- the sensor could include a pressure sensor that measures variation in the pressure in a limb-compressing pneumatic cuff.
- the sensor could employ impedance techniques for monitoring blood flow into and out of an arterial bed, e.g., as now used to non-invasively measure pulsatile cardiac output by measuring impedance across the chest. The same approach could be applied to other part of the body where pulsatile blood flow exists.
- invasive sensors e.g., direct measurements of a parameter
- non-invasive sensors indirect measurements of a parameter
- invasive sensors could also be used, including, for example, pressure sensors coupled to a patient's vascular pressure via a liquid filled catheter, or intravascular pressure sensors, in which the sensor is incorporated onto the tip of a catheter placed in the vascular system.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physiology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Critical Care (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Dentistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Electrotherapy Devices (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
A cardiac resuscitation device that includes a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, an accelerometer configured to detect chest movements of the patient during chest compressions, and memory and processing circuits configured to process the outputs of the pulse sensor and accelerometer to monitor the effect that chest compressions have on the patient's pulse.
Description
This application is a continuation reissue application of U.S. Pat. No. 7,488,293, and is with U.S. patent application Ser. No. 13/025,124, filed on Feb. 10, 2011, now issued U.S. Pat. No. RE44,187, another reissue application of the '293 patent; the '293 patent issued on U.S. patent application Ser. No. 11/228,857, filed on Sep. 15, 2005, which application is a continuation of U.S. patent application Ser. No. 10/441,933, filed on May 20, 2003, now abandoned, which is a continuation in part application of U.S. patent application Ser. No. 10/421,652, entitled “Optical Pulse Sensor for External Defibrillator,” filed on Apr. 23, 2003, now abandoned.
This invention relates to pulse sensors and methods of using pulse sensors in conjunction with external defibrillators.
The pulse is a very important parameter that is used to aid users of automated external defibrillators in determining whether or not to administer a defibrillation shock to and/or to perform cardiopulmonary resuscitation (CPR) on a victim who appears to be in cardiac arrest. Such a victim may actually be in need of cardiac resuscitation (including defibrillation and/or CPR), or may be suffering from a condition for which such treatment would be unsuitable, e.g., a stroke, seizure, diabetic coma, or heat exhaustion. It is very important to the safety of the victim that the presence or absence of a pulse be determined quickly and accurately. However, it is often difficult for trained medical personnel to take a victim's pulse accurately in the field during a crisis situation, and may be impossible for a minimally trained or untrained lay rescuer to do so. In many cases, it will take the person assisting the victim a considerable time (on the order of one minute or more) to find the victim's pulse. If a pulse is not found, the caregiver is left unsure as to whether the victim does not have a pulse, or whether the caregiver simply cannot find the victim's pulse.
Another parameter that is used in determining whether to administer a defibrillation shock is an ECG analysis of the victim's heart rhythm that is provided by the automated external defibrillator. Based on the ECG analysis, many automated defibrillators will provide the user with a message indicating whether a shock should be administered (i.e., whether or not ventricular fibrillation is present).
Generally, the ECG analysis systems in most commercially available automated external defibrillators display only two options to the user: “Shock Advised” or “No Shock Advised.” When “Shock Advised” is output, this means that the patient is in ventricular fibrillation or wide complex ventricular tachycardia above 150 BPM, conditions which are effectively treated by defibrillation. When “No Shock Advised” is output, this means that the patient's heart rhythm is not treatable by defibrillation therapy.
If the message indicates that a shock is not appropriate, this does not necessarily mean that the victim is not in danger. There are two ECG rhythms, generally referred to as asystole and pulseless electrical activity, which should not be treated with defibrillation (and thus will trigger a message not to shock) but nonetheless are extremely serious in that they suggest that the patient's heart rhythm is unaccompanied by sufficient cardiac output (i.e., the patient is close to death). These conditions are treated by administering cardiopulmonary resuscitation (CPR), in an effort to provide blood flow to the heart and vital organs in the hope that with improved blood flow and oxygenation, the heart muscle will recover from its near death state and possibly begin to fibrillate again, thus making defibrillation treatment a viable option.
Thus, when a “No Shock Advised” analysis is output, the caregiver does not know whether this result is caused by a normal heart rhythm, an abnormal but perfusing heart rhythm (i.e., the patient was never in cardiac arrest or the last shock treatment returned the patient's heart rhythm to normal), or a grossly abnormal (non-perfusing) ECG rhythm requiring CPR treatment. Because of this uncertainty, the normal medical protocol when “No Shock Advised” is output is to check the patient for a pulse and if no pulse is detected to start CPR. If a pulse is detected, then the patient's heart is effectively pumping blood and neither CPR nor defibrillation is warranted. If the victim does not have a pulse, CPR should be started immediately; if a pulse is present, then CPR should not be administered. Because CPR, even if properly administered, can result in broken ribs or other injury to the victim, it is undesirable to administer CPR if it is not actually necessary. Thus, it is again vitally important that an accurate determination of the presence or absence of a pulse be made by the caregiver.
A similar situation of uncertainty occurs after the third defibrillation shock is delivered in the three-shock protocol recommended by the American Heart Association. In this case, if the patient's fibrillation has not been “cured” after delivery of three shocks, the caregiver is instructed to perform CPR on the patient. Because automated external defibrillators generally do not perform an ECG analysis immediately after the third shock, the caregiver does not know whether the third shock provided effective treatment. Therefore, the caregiver must determine whether the patient has a pulse in order to determine whether CPR is needed or whether the patient is out of danger.
A wide variety of sensors have been employed for pulse detection.
Optical sensors have been used in pulse detection. For example, pulse detectors of the type used for measuring heart rate during exercise typically rely on reflectance or transmission of an infrared light beam. Blood pulsing in the user's capillaries produces a corresponding variation in the absorption of light by capillaries, and that variation produces a pulsation in the output of an optical sensor.
Optical sensors are also widely used in pulse oximetry, in which a measurement is made of the percentage of hemoglobin saturated with oxygen. An optical plethysmographic probe attached to the patient's finger or ear lobe generates light at two wavelengths (e.g., 650 nm and 805 nm). The light is partially absorbed by hemoglobin, by amounts that differ depending on whether or not the hemoglobin is saturated with oxygen. By calculating absorption at the two wavelengths, a pulse oximetry device can compute the proportion of hemoglobin that is saturated (oxygenated).
Acoustic sensors have also been applied to pulse detection. Typically, the acoustic sensor is configured to detect sounds characteristic of a beating heart (e.g., the action of a heart valve). E.g., Joo U.S. Pat. No. 6,440,082. Some acoustic sensors used for pulse detection are based on piezoelectric devices.
Another use of a piezoelectric devices in pulse detection is proposed in U.S. patent application Ser. No. 9/846,673, filed on May 1, 2001. The piezoelectric device detects motion of the surface of the body resulting from the pulse (e.g., motion resulting from blood flowing in a blood vessel beneath the sensor).
In a first aspect, the invention features a cardiac resuscitation device, comprising a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, wherein the pulse sensor has a pulse sensor output signal as its output, an accelerometer configured to detect chest movements of the patient during chest compressions, wherein the accelerometer has an accelerometer output signal as its output, and memory and processing circuits configured to process the pulse sensor output signal and accelerometer output signal to monitor the effect that chest compressions have on the patient's pulse.
In a second aspect, the memory and processing circuits may be configured to process the pulse sensor output signal in conjunction with the accelerometer output signal to provide information to the user of the device to improve delivery of CPR to the patient.
In a third aspect, the memory and processing circuits may be configured to process the pulse sensor output signal in conjunction with the accelerometer output signal to determine if chest compressions actually result in the movement of blood thus resulting in a pulse.
In preferred implementations, one or more of the following features may be incorporated. The device may comprise a defibrillator for delivering a defibrillation waveform to the patient and chest electrodes for detecting at least one ECG signal on the patient and for delivering a defibrillation waveform to the patient. The memory and processing circuits may be further configured to analyze the pulse sensor output signal in conjunction with the ECG signal to determine whether the patient has a pulse. The pulse rate of the pulse signal may be compared to the pulse rate of the ECG signal. The memory and processing circuits may be configured to process the accelerometer output signal to determine the rate and depth of delivered chest compressions. The memory and processing circuits may be configured to process the pulse sensor output signal to determine the magnitude and frequency of the patient's pulse. A decision whether to deliver a defibrillation waveform to the patient may be based in part on whether processing of the ECG and pulse sensor output signals determines that the patient has a pulse. The defibrillator may comprise an automatic external defibrillator (AED). The invention may further comprise the capability to provide the user with prompts for performing CPR, and wherein the prompts may be dependent at least in part on whether the processing of the pulse signal determines that the patient has a pulse. A determination of whether the patient has a pulse may be undertaken after delivery of the defibrillation waveform, and the user may be informed of the outcome of the determination. The memory and processor circuits may be further configured to make a determination whether to administer CPR to the patient and the determination may be based at least in part on whether it is determined that the patient has a pulse. The memory and processing circuits may be further configured to use the pulse sensor output signal to determine the efficacy of CPR treatment of the patient.
In a further aspect, the inventors have found that an external defibrillator can be configured to determine whether a patient has a pulse by analyzing the output of a pulse sensor in conjunction with the patient's ECG signal to determine whether a pulse is present. In general the invention features applying electrodes to the chest of the patient, detecting at least one ECG signal from electrodes, applying a pulse sensor (of varying kinds) to the patient, detecting a pulse signal from the pulse sensor, and analyzing the pulse signal in conjunction with the ECG signal to determine whether the patient has a pulse.
Preferred implementations of this aspect of the invention may incorporate one or more of the following: The pulse rate of the pulse signal may be compared to the pulse rate of the ECG signal. The pulse signal may be processed to isolate the pulsatile component of the signal. The pulse signal may be examined for a peak during a window initiated at the occurrence of an R-wave in the ECG signal. A comparison may be made of the energy in discrete frequency bands of the pulse and the ECG signals. A peak frequency corresponding to the peak of one of the pulse and ECG signals may be determined, and the other of the pulse and ECG signals may be examined for a peak within a frequency band surrounding the peak frequency. A frequency domain transformation of the pulse signal may be processed. The frequency domain transformations of the pulse and ECG signal may be processed. A decision whether to deliver a defibrillation waveform to the patient may be based in part on whether processing of the ECG and pulse signals determines that the patient has a pulse. The defibrillator may be an automatic external defibrillator (AED). The implementation may include the capability to provide the user with prompts for performing CPR, wherein the prompts are dependent at least in part on whether the processing of the pulse signal determines that the patient has a pulse. A determination of whether the patient has a pulse may be undertaken after delivery of the defibrillation waveform, and the user may be informed of the outcome of the determination. The pulse sensor (e.g., an optical plethysmographic sensor) may be mechanically connected to at least one of the defibrillation electrodes. There may be two defibrillation electrodes, each supported on a substrate, and the pulse sensor may be supported on the same substrate. The wires connected to the pulse sensor may be bundled with wires connected to the defibrillation electrodes to form a combined bundle of wires extending from the defibrillator to the electrodes and sensor. The pulse sensor may be mechanically separate from the defibrillation electrodes. In the case of an optical pulse sensor, the sensor may be configured to be attached to the forehead of the patient to the ear lobe, to the nasal septum, to the nasal bridge, or to the finger. In the case of an optical pulse sensor, the sensor may be configured so that its output may also be used for pulse oximetry, or it may be configured so that its output is not useful for pulse oximetry. Determining whether the patient has a pulse may include determining whether the pulse, if present, is correlated with the R-wave of the patient's heart rhythm. A determination whether to administer CPR to the patient may be based on whether it is determined that the patient has a pulse. The pulse sensor may be to determine the efficacy of CPR treatment of the patient. Analyzing the pulse signal in conjunction with the ECG signal may comprise analyzing whether there is a correlation between the two signals indicative of the presence of a pulse.
A wide variety of pulse sensors may be used. The pulse sensor may include a non-optical sensor. The pulse sensor may be an acoustic (heart sounds) sensor. The pulse sensor may include an ultrasonic blood flow sensor. The pulse sensor may include a pressure sensor on a limb-compressing pneumatic cuff. The pulse sensor may include at least one mechanical or ultrasonic sensor (e.g., a piezoelectric sensor) configured to detect arterial wall motion caused by blood flow in an artery. The pulse sensor may include one or more sensors for measuring body impedance variation from blood flow.
Implementations of the invention have many and various advantages. They can make it possible to perform a quick and accurate determination of the appropriate treatment (defibrillation, CPR, or no cardiac-related treatment) for a patient who appears to be suffering from cardiac arrest. They can provide an accurate determination of the presence or absence of a pulse in a patient, even under adverse conditions, thus significantly reducing the risk that an inappropriate and even dangerous treatment will be given erroneously. The accurate pulse determination thus provided relieves the uncertainty experienced by caregivers in the circumstances discussed above, and thus increases the likelihood of the patient receiving prompt, safe and effective treatment. For example, a pulse sensor can be used to determine whether CPR is necessary, in the event that an automated defibrillator indicates that it is not appropriate to shock a patient who appears to be suffering from cardiac arrest.
In some implementations, in which the pulse sensor is an optical sensor, the invention provides an optical sensor without the complexity of pulse oximetry, in which two optical measurements, one at each of two wavelengths, are made, and complex signal processing is performed to estimate blood oxygen saturation from the two measurements.
Other features and advantages of the invention will be apparent from the drawings, detailed description, and claims.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
There are a great many possible implementations of the invention, too many to describe herein. Some possible implementations that are presently preferred are described below. It cannot be emphasized too strongly, however, that these are descriptions of implementations of the invention, and not descriptions of the invention, which is not limited to the detailed implementations described in this section but is described in broader terms in the claims.
The descriptions below are more than sufficient for one skilled in the art to construct the disclosed implementations. Unless otherwise mentioned, the processes and manufacturing methods referred to are ones known by those working in the art
The optical plethysmographic sensor 22 detects transmitted or reflected light, and provides a pulse signal 34, which represents a parameter correlated with the patient's pulse. In the case of an optical plethysmographic sensor, the pulse signal 34 would be an optical signal representing the brightness of light transmitted through or reflected from a portion of the body through which blood capillaries extend. The term “pulse signal” is simply a shorthand for an electrical signal representative of a parameter correlated with the pulse of the patient. E.g, in the case of an optical sensor, the pulse signal could be the light sensed by the optical receiver. If the patient has a pulse, there will generally be a pulsing variation in the pulse signal. In the case of an optical sensor, the variation will be in the absorption of light by the blood capillaries.
A variety of signal processing techniques may be used to process the pulse signal to determine whether a pulse is present or absent. Several possibilities are described below. These may be used alone or in combination.
One processing technique is to process the pulse signal 34 to isolate any pulsatile component. FIG. 3 shows a typical pulse signal 34 that would be detected when a pulse is present. A time domain analysis can be performed on the pulse signal to determine whether it contains a pulsatile component. For example, the non-pulsatile component can be estimated as the mean of the pulse signal, and variation from the mean can be analyzed for the presence of a pulsatile component indicative of a pulse. The frequency and strength of the pulsatile component (i.e., the variation from the mean) can be compared to predetermined frequency ranges and strength ranges to decide whether a pulse is present.
The pulse signal may be filtered so that pulses in the waveform are enhanced and then detected with a beat detection algorithm (e.g., the algorithm conventionally utilized for ECG R-wave detection). The filtering may include a high pass filter, a low pass filter, and also a notch filter to remove line noise if necessary. The high pass filter with a −3 dB cutoff frequency near 0.5 Hz removes any DC component, thus enhancing any existing pulsatile component. The low pass filter, with a −3 dB point in the range of 5-15 Hz removes some signal components unrelated to patients' pulse (i.e., noise). A smoothed or unsmoothed difference operation may also be applied to the pulse signal as one method to enhance or precondition the pulse signal for a time-domain beat detection algorithm. FIG. 3A illustrates a raw pulse signal, and FIG. 3B shows a filtered, preconditioned pulse signal ready to be processed by a beat detection algorithm.
The beat detection algorithm of FIG. 4 may be applied to the preconditioned pulse signal of FIG. 3B . The beat detection algorithm is intended to identify individual pulses within the pulse waveform. The arrows at the bottom of FIG. 3B indicate detection of a beat by the algorithm. Time intervals may then be computed between any two successive pulse detections. These time intervals, derived from the pulse waveform, may then by analyzed to determine the likelihood of a pulse. A moving average of these intervals may also be computed and updated as new intervals are measured. If the average interval is within a range (e.g. 35-185 beats/minute), then a pulse might be declared present.
Another processing technique is to use both a pulse signal from the pulse sensor and an ECG signal from the electrodes. Typically, both the pulse signal and the ECG signal will exhibit periodicity when a pulse is present, because a true pulse originates from a mechanically beating heart, and thus the same periodicity observed on the pulse signal should be present on the ECG signal when the heart is beating. However, a periodic ECG signal is not always indicative of a pulse, and thus should only be used to verify (or in combination with) periodicity detected in the pulse signal.
A simpler technique is to determine the pulse rate of each of the ECG and pulse signals, and simply compare the two pulse rates. If the difference between the two rates is within a range (e.g., 1-5 beats/minute), the existence of a pulse is declared. This technique may be used in conjunction with the pulse windowing scheme to minimize the number of false positive detections on the pulse signal. If the implementation does not employ a method (e.g., windowing scheme) to minimize false positive detections on the pulse signal, then the comparison between pulse and ECG derived pulse rates may be modified. In this case the absence of a pulse would be declared if the pulse rate is less than the ECG rate. This modification takes into consideration that the pulse rate may be higher than the ECG rate due to false pulse detections, and such a condition may be indicative of a pulse despite the difference between the two rates being outside of a range.
Another technique is to compare band-limited versions of the ECG and pulse signals. The signals can be band limited over a range of likely pulse frequencies (e.g., 0.5-5 Hz). The band-limited signals are compared to determine if a pulse or peak frequency of the pulse signal compares well with a pulse or peak frequency of the ECG signal. If the two compare well, the existence of a patient pulse is supported. Comparisons can be made using several different quantitative techniques. Cross correlation (convolution) of the two filtered waveforms is one technique that can be used to quantify the comparison of the two waveforms.
One technique for comparing the peak frequencies of the two signals is shown in FIG. 7 . Each of the ECG and pulse signals is transformed into a frequency domain using, e.g., an FFT, wavelet, or other transform. The frequency peak of the transformed pulse signal is then compared with the ECG derived heart rate or peak frequency. An association between the two frequency peaks supports the existence of a pulse. A quantitative technique for determining how well the two frequency peaks compare is suggested in FIG. 7 . The energy levels in discrete frequency bands are compared, e.g., the a-b band 60 in the ECG transform is compared to the a-b band 62 in the pulse signal transform.
The peak frequencies can also be compared by examining one signal for a peak located within a predetermined frequency band centered on the peak frequency of the other signal. For example, as shown in FIG. 8 , the peak ECG frequency 70 could be measured and updated at regular intervals (which could be constant or variable as a function of heart rate), with the measurement being done either in the time domain or in a transformed frequency domain. The pulse signal 74 would then be examined for a corresponding peak frequency within a band 72 centered on the continuously updated peak ECG frequency (e.g., using an adaptive filter). The existence of a peak on the pulse signal within the ECG determined band supports the existence of a pulse. In FIG. 8 , the peak in the pulse signal is outside the band, thus suggesting that a pulse is not present.
The autocorrelation of the ECG signal can also be compared with the autocorrelation of the pulse signal. Comparing autocorrelation signals improves the signal to noise ratio and may be particularly useful if the periodic component of the signals is small. The two autocorrelation signals may be compared using a cross-coeerlation. The comparison determines if the periodicity of the two autocorrelated signals are similar. Similar periodicities support the existence of a pulse.
The addition of a pulse detection system adds significant improvements to automatic and semi-automatic external defibrillators. The addition of a pulse detection system will reduce the number of inappropriate shock advisements. Particularly in cases where patients have a pulse, but have been incorrectly classified by the ECG analysis algorithm as having a shockable rhythm. As shown in the table of FIG. 9 , the addition of the pulse detection system will override the shock advisement from the ECG analysis algorithm thereby appropriately inhibiting defibrillation therapy. The addition of a pulse detection system will also enable the defibrillator to advise the rescuer when CPR is appropriate and inappropriate. In the case where the ECG analysis algorithm advises “No Shock” and the pulse detection algorithm indicates “No Pulse”, the defibrillator may indicate to the rescuer that CPR should be administered. Conversely, detection of a pulse by the pulse detection system may be used to indicate to the rescuer that CPR is no longer necessary.
The pulse detection system may also be used to improve the defibrillator system by providing feedback to the rescuer during the administration of CPR. In this scenario, the pulse detection system may be utilized to monitor the effect that chest compressions have on a patients pulse. The detected magnitude and frequency of a pulse by the pulse detection system may be used independently or in conjunction with accelerometer data to aid the rescuer in delivering optimal CPR to the victim. Whereas an accelerometer may be used to measure the rate and depth of delivered chest compressions, a pulse detection system may be used to determine if these chest compressions actually result in the movement of blood thus resulting in a pulse.
A wide variety of pulse sensors may be used. For example, the sensor could be optical or non-optical. It could include an acoustic sensor (e.g., amplified stethoscope signals) for detecting heart sounds characteristic of a beating heart. It could include a sensor capable of mechanical or ultrasonic measurement (e.g., piezoelectric) of arterial wall motion—e.g., in locations such as the neck (carotid arteries), arms (radial and brachial arteries), and legs (femoral artery) where the arteries are relatively close to the surface. It could include an ultrasonic measurement of blood flow (e.g., such as the ultrasonic blood flow detectors used to detect carotid and/or femoral artery stenosis). It could include a pressure sensor that measures variation in the pressure in a limb-compressing pneumatic cuff. The sensor could employ impedance techniques for monitoring blood flow into and out of an arterial bed, e.g., as now used to non-invasively measure pulsatile cardiac output by measuring impedance across the chest. The same approach could be applied to other part of the body where pulsatile blood flow exists.
Both invasive (e.g., direct measurements of a parameter) and non-invasive (indirect measurements of a parameter) sensors can be used The examples given above are generally non-invasive. But invasive sensors could also be used, including, for example, pressure sensors coupled to a patient's vascular pressure via a liquid filled catheter, or intravascular pressure sensors, in which the sensor is incorporated onto the tip of a catheter placed in the vascular system.
Many other implementations of the invention other than those described above are within the invention, which is defined by the following claims.
Claims (13)
1. A cardiac resuscitation device, comprising
a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, wherein the pulse sensor has a pulse sensor output signal as its output, and wherein the pulse sensor output signal contains information characterizing individual pulses, each corresponding to movement of blood in the patient's circulatory system;
an accelerometer configured to detect chest movements of the patient during a series of individual chest compressions, wherein the accelerometer has an accelerometer output signal as its output; and
memory and processing circuits configured to process the pulse sensor output signal in conjunction with the accelerometer output signal to determine, for each of a plurality of individual chest compressions in the series of individual chest compressions, if the individual chest compression actually caused movement of blood thus resulting in an individual pulse.
2. The device of claim 1 wherein the device comprises a defibrillator for delivering a defibrillation waveform to the patient and chest electrodes for detecting at least one ECG signal on the patient and for delivering a defibrillation waveform to the patient.
3. The device of claim 2 wherein the memory and processing circuits are further configured to analyze the pulse sensor output signal in conjunction with the ECG signal.
4. The device of claim 3 wherein the pulse rate of the pulse signal is compared to the pulse rate of the ECG signal.
5. The subject matter of claim 2 wherein the defibrillator comprises an automatic external defibrillator (AED).
6. The subject matter of claim 5 further comprising the capability to provide the user with prompts for performing CPR, and wherein the prompts are dependent at least in part on whether the processing of the pulse signal determines that individual chest compressions actually cause movements of blood and thus individual pulses.
7. The device of claim 1 wherein the memory and processing circuits are configured to process the accelerometer output signal to determine the rate and depth of delivered individual chest compressions.
8. The device of claim 1 wherein the memory and processing circuits are configured to process the pulse sensor output signal to determine the magnitude and frequency of the patient's pulse.
9. The subject matter of claim 1 wherein the memory and processing circuits are further configured to determine the efficacy of CPR treatment of the patient.
10. A cardiac resuscitation device, comprising
a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, wherein the pulse sensor has a pulse sensor output signal as its output, and wherein the pulse sensor output signal contains information characterizing individual pulses, each corresponding to movement of blood in the patient's circulatory system;
a sensor configured to detect chest movements of the patient during a series of individual chest compressions, wherein the sensor has a sensor output signal as its output; and
memory and processing circuits configured to process the pulse sensor output signal in conjunction with the sensor output signal to determine, for each of a plurality of individual chest compressions in the series of individual chest compressions, if the individual chest compression actually caused movement of blood thus resulting in an individual pulse,
wherein the pulse sensor and memory and processing circuits are further configured to provide the user with prompts for performing CPR, and wherein the prompts are dependent at least in part on whether the processing of the pulse signal determines that individual chest compressions actually cause movements of blood and thus individual pulses.
11. A cardiac resuscitation device, comprising
a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, wherein the pulse sensor has a pulse sensor output signal as its output, and wherein the pulse sensor output signal contains information characterizing individual pulses, each corresponding to movement of blood in the patient's circulatory system;
a sensor configured to detect chest movements of the patient during a series of individual chest compressions, wherein the sensor has a sensor output signal as its output; and
memory and processing circuits configured to process the pulse sensor output signal in conjunction with the sensor output signal to determine, for each of a plurality of individual chest compressions in the series of individual chest compressions, if the individual chest compression actually caused movement of blood thus resulting in an individual pulse,
wherein the pulse sensor and memory and processing circuits are configured to process the pulse sensor output signal throughout a cardiac resuscitation to determine when the patient exhibits a pulse sufficient to not require further CPR.
12. The device of claim 11 wherein the pulse sensor and memory and processing circuits are configured to provide the user with a prompt indicating that further CPR is not required.
13. A cardiac resuscitation device, comprising
a pulse sensor configured to detect pulse information characterizing the cardiac pulse in the patient, wherein the pulse sensor has a pulse sensor output signal as its output, and wherein the pulse sensor output signal contains information characterizing individual pulses, each corresponding to movement of blood in the patient's circulatory system;
a sensor configured to detect chest movements of the patient during a series of individual chest compressions, wherein the sensor has a sensor output signal as its output; and
memory and processing circuits configured to process the pulse sensor output signal in conjunction with the sensor output signal to determine, for each of a plurality of individual chest compressions in the series of individual chest compressions, if the individual chest compression actually caused movement of blood thus resulting in an individual pulse,
wherein the pulse sensor and memory and processing circuits are configured to process the pulse sensor output signal throughout a cardiac resuscitation to inform the user of when the patient's pulse returns.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/872,037 USRE45922E1 (en) | 2003-04-23 | 2013-04-26 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42165203A | 2003-04-23 | 2003-04-23 | |
US10/441,933 US20040215244A1 (en) | 2003-04-23 | 2003-05-20 | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
US13/025,124 USRE44187E1 (en) | 2003-04-23 | 2011-02-10 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
US13/872,037 USRE45922E1 (en) | 2003-04-23 | 2013-04-26 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/228,857 Reissue US7488293B2 (en) | 2003-04-23 | 2005-09-15 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE45922E1 true USRE45922E1 (en) | 2016-03-15 |
Family
ID=33313120
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/441,933 Abandoned US20040215244A1 (en) | 2003-04-23 | 2003-05-20 | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
US10/958,953 Abandoned US20050043763A1 (en) | 2003-04-23 | 2004-10-05 | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
US11/228,857 Ceased US7488293B2 (en) | 2003-04-23 | 2005-09-15 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
US13/025,124 Expired - Fee Related USRE44187E1 (en) | 2003-04-23 | 2011-02-10 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
US13/872,037 Expired - Lifetime USRE45922E1 (en) | 2003-04-23 | 2013-04-26 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/441,933 Abandoned US20040215244A1 (en) | 2003-04-23 | 2003-05-20 | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
US10/958,953 Abandoned US20050043763A1 (en) | 2003-04-23 | 2004-10-05 | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
US11/228,857 Ceased US7488293B2 (en) | 2003-04-23 | 2005-09-15 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
US13/025,124 Expired - Fee Related USRE44187E1 (en) | 2003-04-23 | 2011-02-10 | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
Country Status (2)
Country | Link |
---|---|
US (5) | US20040215244A1 (en) |
WO (1) | WO2004093651A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180055382A1 (en) * | 2016-08-23 | 2018-03-01 | Covidien Lp | Automatic estimation of pulse deficit |
WO2018165634A1 (en) * | 2017-03-09 | 2018-09-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems, devices, and methods for monitoring and modulation of therapeutic procedures |
US10542961B2 (en) | 2015-06-15 | 2020-01-28 | The Research Foundation For The State University Of New York | System and method for infrasonic cardiac monitoring |
Families Citing this family (193)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7758503B2 (en) * | 1997-01-27 | 2010-07-20 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
US20060155207A1 (en) * | 1997-01-27 | 2006-07-13 | Lynn Lawrence A | System and method for detection of incomplete reciprocation |
US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US20080287756A1 (en) * | 1997-07-14 | 2008-11-20 | Lynn Lawrence A | Pulse oximetry relational alarm system for early recognition of instability and catastrophic occurrences |
US20070191697A1 (en) | 2006-02-10 | 2007-08-16 | Lynn Lawrence A | System and method for SPO2 instability detection and quantification |
US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US20050131465A1 (en) | 2000-02-04 | 2005-06-16 | Freeman Gary A. | Integrated resuscitation |
WO2001056652A1 (en) * | 2000-02-04 | 2001-08-09 | Zmd Corporation | Integrated resuscitation |
US20060064131A1 (en) * | 2000-02-04 | 2006-03-23 | Freeman Gary A | User interface for defibrillator for use by persons with limited training and experience |
US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
US20060195041A1 (en) | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US20070093721A1 (en) * | 2001-05-17 | 2007-04-26 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
US20040116969A1 (en) | 2002-08-26 | 2004-06-17 | Owen James M. | Pulse detection using patient physiological signals |
EP1549165B8 (en) | 2002-10-01 | 2010-10-06 | Nellcor Puritan Bennett LLC | Use of a headband to indicate tension and system comprising an oximetry sensor and a headband |
US6827695B2 (en) | 2002-10-25 | 2004-12-07 | Revivant Corporation | Method of determining depth of compressions during cardio-pulmonary resuscitation |
US6961612B2 (en) * | 2003-02-19 | 2005-11-01 | Zoll Medical Corporation | CPR sensitive ECG analysis in an automatic external defibrillator |
JP4526532B2 (en) | 2003-02-27 | 2010-08-18 | ネルコア ピューリタン ベネット アイルランド | Signal analysis and processing methods |
US20040215244A1 (en) * | 2003-04-23 | 2004-10-28 | Marcovecchio Alan F. | Processing pulse signal in conjunction with ECG signal to detect pulse in external defibrillation |
EP1622508B1 (en) * | 2003-05-12 | 2014-04-09 | Cheetah Medical, Inc. | System and method for measuring blood flow and blood volume |
US7047056B2 (en) | 2003-06-25 | 2006-05-16 | Nellcor Puritan Bennett Incorporated | Hat-based oximeter sensor |
US7792571B2 (en) | 2003-06-27 | 2010-09-07 | Cardiac Pacemakers, Inc. | Tachyarrhythmia detection and discrimination based on curvature parameters |
US8412297B2 (en) | 2003-10-01 | 2013-04-02 | Covidien Lp | Forehead sensor placement |
JP2012091021A (en) | 2003-11-06 | 2012-05-17 | Zoll Medical Corp | Device for analyzing physiological signal during application of chest compression |
US20050101889A1 (en) | 2003-11-06 | 2005-05-12 | Freeman Gary A. | Using chest velocity to process physiological signals to remove chest compression artifacts |
WO2005112749A1 (en) | 2004-05-12 | 2005-12-01 | Zoll Medical Corporation | Ecg rhythm advisory method |
US7565194B2 (en) | 2004-05-12 | 2009-07-21 | Zoll Medical Corporation | ECG rhythm advisory method |
US7164938B2 (en) * | 2004-06-21 | 2007-01-16 | Purdue Research Foundation | Optical noninvasive vital sign monitor |
US9259543B2 (en) | 2004-10-25 | 2016-02-16 | Zoll Medical Corporation | Non-invasive device for synchronizing chest compression and ventilation parameters to residual myocardial activity during cardiopulmonary resuscitation |
US8401637B2 (en) * | 2004-11-24 | 2013-03-19 | Galvani, Ltd. | Medium voltage therapy applications in treating cardiac arrest |
US7937146B2 (en) * | 2005-01-26 | 2011-05-03 | Physio-Control, Inc. | Defibrillator with overridable CPR-first protocol |
GB0502871D0 (en) * | 2005-02-10 | 2005-03-16 | Cardiodigital Ltd | ECG analysis during CPR |
EP1848326B1 (en) | 2005-02-15 | 2016-11-16 | Cheetah Medical, Inc. | System, method and apparatus for measuring blood flow and blood volume |
DE102005031642B4 (en) * | 2005-07-06 | 2008-05-29 | Siemens Ag | Mobile defibrillator |
EP1906818A2 (en) * | 2005-07-15 | 2008-04-09 | Koninklijke Philips Electronics N.V. | Apparatus and method for defibrillation pulse detection using electromagnetic waves |
US7650181B2 (en) * | 2005-09-14 | 2010-01-19 | Zoll Medical Corporation | Synchronization of repetitive therapeutic interventions |
US7483731B2 (en) | 2005-09-30 | 2009-01-27 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
CN101365387A (en) * | 2005-11-17 | 2009-02-11 | 皇家飞利浦电子股份有限公司 | Cpr guided by vascular flow measurement |
US7668579B2 (en) * | 2006-02-10 | 2010-02-23 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
DE102006024459A1 (en) * | 2006-05-24 | 2007-11-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | A sensor, processing device, method and computer program for providing information about a vital parameter of a living being |
US8010190B2 (en) | 2006-05-26 | 2011-08-30 | Cardiac Science Corporation | CPR feedback method and apparatus |
WO2008015624A2 (en) * | 2006-08-03 | 2008-02-07 | Koninklijke Philips Electronics, N.V. | Cpr coaching device having internal sensor for sensing a physiological characteristic |
US9095271B2 (en) * | 2007-08-13 | 2015-08-04 | Cheetah Medical, Inc. | Dynamically variable filter |
US8876725B2 (en) * | 2007-02-23 | 2014-11-04 | Cheetah Medical, Inc. | Method and system for estimating exercise capacity |
US9138573B2 (en) * | 2007-03-07 | 2015-09-22 | Zoll Medical Corporation | External defibrillators,transcutaneous electrodes for same, and methods of use |
EP2131737B1 (en) * | 2007-03-07 | 2015-04-29 | Cheetah Medical, Inc. | Method and system for monitoring sleep |
US9314610B2 (en) * | 2007-03-08 | 2016-04-19 | Zoll Medical Corporation | Defibrillation electrodes |
FR2913588B1 (en) * | 2007-03-12 | 2010-05-07 | Groupe Ecoles Telecomm | AMBULATORY TELEVIGILANCE SYSTEM COMPRISING A DEVICE FOR PULSE DEBRISING, ACTIMETRY AND FALL DETECTION |
CA2683684C (en) * | 2007-04-19 | 2016-02-02 | Cheetah Medical Ltd. | Method, apparatus and system for predicting electromechanical dissociation |
EP2157962A2 (en) * | 2007-06-01 | 2010-03-03 | Cardiac Science, Inc. | System, method, and apparatus for assisting a rescuer in resuscitation |
US8369944B2 (en) * | 2007-06-06 | 2013-02-05 | Zoll Medical Corporation | Wearable defibrillator with audio input/output |
US8271082B2 (en) * | 2007-06-07 | 2012-09-18 | Zoll Medical Corporation | Medical device configured to test for user responsiveness |
US7974689B2 (en) | 2007-06-13 | 2011-07-05 | Zoll Medical Corporation | Wearable medical treatment device with motion/position detection |
US8140154B2 (en) | 2007-06-13 | 2012-03-20 | Zoll Medical Corporation | Wearable medical treatment device |
US8034006B2 (en) * | 2007-06-15 | 2011-10-11 | Board Of Regents, The University Of Texas System | Cardiopulmonary resuscitation sensor |
US8994528B2 (en) * | 2007-06-15 | 2015-03-31 | Board Of Regents, The University Of Texas System | Thin flexible sensor |
US7682316B2 (en) * | 2007-07-23 | 2010-03-23 | Medtronic, Inc. | Implantable heart sound sensor with noise cancellation |
WO2009069037A2 (en) * | 2007-11-27 | 2009-06-04 | Koninklijke Philips Electronics, N.V. | Aural heart monitoring apparatus and method |
WO2009072024A1 (en) * | 2007-12-05 | 2009-06-11 | Koninklijke Philips Electronics, N.V. | Forehead mounted biometric sensor with motion artifact reducing system and method |
US8511308B2 (en) * | 2007-12-06 | 2013-08-20 | Cpair, Inc. | CPR system with feed back instruction |
US8571643B2 (en) | 2010-09-16 | 2013-10-29 | Flint Hills Scientific, Llc | Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex |
US8337404B2 (en) | 2010-10-01 | 2012-12-25 | Flint Hills Scientific, Llc | Detecting, quantifying, and/or classifying seizures using multimodal data |
US8382667B2 (en) | 2010-10-01 | 2013-02-26 | Flint Hills Scientific, Llc | Detecting, quantifying, and/or classifying seizures using multimodal data |
US8275553B2 (en) | 2008-02-19 | 2012-09-25 | Nellcor Puritan Bennett Llc | System and method for evaluating physiological parameter data |
EP2283443A1 (en) | 2008-05-07 | 2011-02-16 | Lynn, Lawrence A. | Medical failure pattern search engine |
WO2009138902A1 (en) * | 2008-05-13 | 2009-11-19 | Koninklijke Philips Electronics N.V. | Integrated patient monitoring device |
US8385675B2 (en) * | 2008-07-15 | 2013-02-26 | Nellcor Puritan Bennett Ireland | Systems and methods for filtering a signal using a continuous wavelet transform |
US20100016676A1 (en) | 2008-07-15 | 2010-01-21 | Nellcor Puritan Bennett Ireland | Systems And Methods For Adaptively Filtering Signals |
US8257274B2 (en) * | 2008-09-25 | 2012-09-04 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
US11382571B2 (en) | 2008-10-29 | 2022-07-12 | Flashback Technologies, Inc. | Noninvasive predictive and/or estimative blood pressure monitoring |
US11395594B2 (en) | 2008-10-29 | 2022-07-26 | Flashback Technologies, Inc. | Noninvasive monitoring for fluid resuscitation |
US11406269B2 (en) | 2008-10-29 | 2022-08-09 | Flashback Technologies, Inc. | Rapid detection of bleeding following injury |
US11857293B2 (en) | 2008-10-29 | 2024-01-02 | Flashback Technologies, Inc. | Rapid detection of bleeding before, during, and after fluid resuscitation |
US11478190B2 (en) | 2008-10-29 | 2022-10-25 | Flashback Technologies, Inc. | Noninvasive hydration monitoring |
US11395634B2 (en) | 2008-10-29 | 2022-07-26 | Flashback Technologies, Inc. | Estimating physiological states based on changes in CRI |
US12201405B2 (en) * | 2008-10-29 | 2025-01-21 | Flashback Technologies, Inc. | Assessing effectiveness of CPR |
US8512260B2 (en) | 2008-10-29 | 2013-08-20 | The Regents Of The University Of Colorado, A Body Corporate | Statistical, noninvasive measurement of intracranial pressure |
US8515515B2 (en) | 2009-03-25 | 2013-08-20 | Covidien Lp | Medical sensor with compressible light barrier and technique for using the same |
US8781548B2 (en) | 2009-03-31 | 2014-07-15 | Covidien Lp | Medical sensor with flexible components and technique for using the same |
RU2597135C2 (en) | 2009-06-26 | 2016-09-10 | Золл Медикал Корпорейшн | Defibrillation electrodes |
US8483822B1 (en) | 2009-07-02 | 2013-07-09 | Galvani, Ltd. | Adaptive medium voltage therapy for cardiac arrhythmias |
US20110172550A1 (en) * | 2009-07-21 | 2011-07-14 | Michael Scott Martin | Uspa: systems and methods for ems device communication interface |
WO2011011454A1 (en) | 2009-07-21 | 2011-01-27 | Zoll Medical Corporation | Systems and methods for collection, organization and display of ems information |
US20110021892A1 (en) * | 2009-07-23 | 2011-01-27 | Nellcor Puritan Bennett Ireland | Systems and methods for respiration monitoring |
US20110021941A1 (en) * | 2009-07-23 | 2011-01-27 | Nellcor Puritan Bennett Ireland | Systems and methods for respiration monitoring |
US8478376B2 (en) * | 2009-07-30 | 2013-07-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining physiological information using selective transform data |
CA2771856A1 (en) * | 2009-09-24 | 2011-03-31 | Nellcor Puritan Bennett Llc | Determination of a physiological parameter |
US8923945B2 (en) * | 2009-09-24 | 2014-12-30 | Covidien Lp | Determination of a physiological parameter |
US20110077484A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Ireland | Systems And Methods For Identifying Non-Corrupted Signal Segments For Use In Determining Physiological Parameters |
US8509881B2 (en) * | 2009-11-03 | 2013-08-13 | Cardiac Science Corporation | True ECG measurement during cardio pulmonary resuscitation by adaptive piecewise stitching algorithm |
US8483788B2 (en) * | 2010-02-28 | 2013-07-09 | Covidien Lp | Motion compensation in a sensor |
EP4053760A1 (en) | 2010-04-09 | 2022-09-07 | Zoll Medical Corporation | Systems and methods for ems device communications interface |
US8649871B2 (en) | 2010-04-29 | 2014-02-11 | Cyberonics, Inc. | Validity test adaptive constraint modification for cardiac data used for detection of state changes |
US8831732B2 (en) | 2010-04-29 | 2014-09-09 | Cyberonics, Inc. | Method, apparatus and system for validating and quantifying cardiac beat data quality |
US8562536B2 (en) | 2010-04-29 | 2013-10-22 | Flint Hills Scientific, Llc | Algorithm for detecting a seizure from cardiac data |
US9008801B2 (en) | 2010-05-18 | 2015-04-14 | Zoll Medical Corporation | Wearable therapeutic device |
WO2011146482A1 (en) | 2010-05-18 | 2011-11-24 | Zoll Medical Corporation | Wearable ambulatory medical device with multiple sensing electrodes |
WO2011150343A1 (en) | 2010-05-28 | 2011-12-01 | Zoll Medical Corporation | Systems and methods for enhanced venous return flow |
US10493289B2 (en) | 2010-07-09 | 2019-12-03 | Zoll Medical Corporation | System and method for conserving power in a medical device |
US8641646B2 (en) | 2010-07-30 | 2014-02-04 | Cyberonics, Inc. | Seizure detection using coordinate data |
US20110034835A1 (en) * | 2010-09-07 | 2011-02-10 | Reid Evans | Palm-held CPR helper medical device |
US8684921B2 (en) | 2010-10-01 | 2014-04-01 | Flint Hills Scientific Llc | Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis |
US9937355B2 (en) | 2010-11-08 | 2018-04-10 | Zoll Medical Corporation | Remote medical device alarm |
JP5963767B2 (en) | 2010-12-09 | 2016-08-03 | ゾール メディカル コーポレイションZOLL Medical Corporation | Electrode assembly |
WO2012078937A1 (en) | 2010-12-10 | 2012-06-14 | Zoll Medical Corporation | Wearable therapeutic device |
US9427564B2 (en) | 2010-12-16 | 2016-08-30 | Zoll Medical Corporation | Water resistant wearable medical device |
US9504390B2 (en) | 2011-03-04 | 2016-11-29 | Globalfoundries Inc. | Detecting, assessing and managing a risk of death in epilepsy |
WO2012135062A1 (en) | 2011-03-25 | 2012-10-04 | Zoll Medical Corporation | Selection of optimal channel for rate determination |
US9684767B2 (en) | 2011-03-25 | 2017-06-20 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
WO2012135028A1 (en) | 2011-03-25 | 2012-10-04 | Zoll Medical Corporation | Method of detecting signal clipping in a wearable ambulatory medical device |
JP6166253B2 (en) | 2011-03-25 | 2017-07-19 | ゾール メディカル コーポレイションZOLL Medical Corporation | Controller and method for adapting alarms in wearable medical devices |
US8725239B2 (en) | 2011-04-25 | 2014-05-13 | Cyberonics, Inc. | Identifying seizures using heart rate decrease |
US9402550B2 (en) | 2011-04-29 | 2016-08-02 | Cybertronics, Inc. | Dynamic heart rate threshold for neurological event detection |
WO2012151160A1 (en) | 2011-05-02 | 2012-11-08 | Zoll Medical Corporation | Patient-worn energy delivery apparatus and techniques for sizing same |
US10598508B2 (en) | 2011-05-09 | 2020-03-24 | Zoll Medical Corporation | Systems and methods for EMS navigation user interface |
WO2013016212A1 (en) | 2011-07-22 | 2013-01-31 | Flashback Technologies, Inc. | Hemodynamic reserve monitor and hemodialysis control |
CN103764222B (en) | 2011-09-01 | 2016-02-10 | 佐尔医药公司 | Wearable monitoring and therapeutic equipment |
WO2013049798A1 (en) * | 2011-09-30 | 2013-04-04 | Whitfield Jonathan M | Heart rate and pulse monitoring device |
US9549677B2 (en) | 2011-10-14 | 2017-01-24 | Flint Hills Scientific, L.L.C. | Seizure detection methods, apparatus, and systems using a wavelet transform maximum modulus algorithm |
WO2013130957A2 (en) | 2012-03-02 | 2013-09-06 | Zoll Medical Corporation | Systems and methods for configuring a wearable medical monitoring and/or treatment device |
US9126055B2 (en) | 2012-04-20 | 2015-09-08 | Cardiac Science Corporation | AED faster time to shock method and device |
US8942800B2 (en) | 2012-04-20 | 2015-01-27 | Cardiac Science Corporation | Corrective prompting system for appropriate chest compressions |
US10448839B2 (en) | 2012-04-23 | 2019-10-22 | Livanova Usa, Inc. | Methods, systems and apparatuses for detecting increased risk of sudden death |
US9681836B2 (en) | 2012-04-23 | 2017-06-20 | Cyberonics, Inc. | Methods, systems and apparatuses for detecting seizure and non-seizure states |
US11097107B2 (en) | 2012-05-31 | 2021-08-24 | Zoll Medical Corporation | External pacing device with discomfort management |
IN2014DN09885A (en) | 2012-05-31 | 2015-08-07 | Zoll Medical Corp | |
IN2014DN09896A (en) | 2012-05-31 | 2015-08-07 | Zoll Medical Corp | |
US10328266B2 (en) | 2012-05-31 | 2019-06-25 | Zoll Medical Corporation | External pacing device with discomfort management |
US10127810B2 (en) | 2012-06-07 | 2018-11-13 | Zoll Medical Corporation | Vehicle safety and driver condition monitoring, and geographic information based road safety systems |
EP2859414A4 (en) | 2012-06-07 | 2016-01-27 | Zoll Medical Corp | Systems and methods for video capture, user feedback, reporting, adaptive parameters, and remote data access in vehicle safety monitoring |
US20140012144A1 (en) * | 2012-07-09 | 2014-01-09 | William E. Crone | Perfusion detection system |
US8750990B1 (en) | 2012-12-12 | 2014-06-10 | Galvani, Ltd. | Coordinated medium voltage therapy for improving effectiveness of defibrillation therapy |
US10220211B2 (en) | 2013-01-22 | 2019-03-05 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
US9999393B2 (en) | 2013-01-29 | 2018-06-19 | Zoll Medical Corporation | Delivery of electrode gel using CPR puck |
US8880196B2 (en) | 2013-03-04 | 2014-11-04 | Zoll Medical Corporation | Flexible therapy electrode |
US20140323928A1 (en) * | 2013-04-30 | 2014-10-30 | Zoll Medical Corporation | Compression Depth Monitor with Variable Release Velocity Feedback |
EP2994870A4 (en) | 2013-05-10 | 2017-02-15 | Zoll Medical Corporation | Scoring, evaluation, and feedback related to ems clinical and operational performance |
CN105491987A (en) * | 2013-06-25 | 2016-04-13 | 卓尔医疗公司 | Integrated resuscitation apparatus including perfusion monitor |
CN105246399B (en) * | 2013-06-26 | 2017-10-03 | 英特尔公司 | The detection of leading stroke risk index |
ES2894750T3 (en) | 2013-06-28 | 2022-02-15 | Zoll Medical Corp | Therapy delivery systems using an ambulatory medical device |
US20150088016A1 (en) | 2013-09-25 | 2015-03-26 | Zoll Medical Corporation | Mobile Device Control |
US10022068B2 (en) | 2013-10-28 | 2018-07-17 | Covidien Lp | Systems and methods for detecting held breath events |
US12076483B2 (en) | 2013-12-09 | 2024-09-03 | Exemplar Medical LLC | Portable apparatus for providing chest therapy |
US9901510B2 (en) | 2013-12-09 | 2018-02-27 | Brett Gene Smith | Portable apparatus for providing chest therapy |
US10959912B2 (en) | 2013-12-09 | 2021-03-30 | Exemplar Medical LLC | Portable apparatus for providing chest therapy |
EP3082577B1 (en) | 2013-12-19 | 2020-09-16 | Koninklijke Philips N.V. | Method and heart rate monitor with accelerometers for pulse detection |
US9597523B2 (en) | 2014-02-12 | 2017-03-21 | Zoll Medical Corporation | System and method for adapting alarms in a wearable medical device |
WO2015153810A1 (en) | 2014-04-01 | 2015-10-08 | NuLine Sensors, LLC | Cardiopulmonary resuscitation (cpr) feedback systems and methods |
WO2015200813A1 (en) * | 2014-06-26 | 2015-12-30 | University Of Washington | Apparatuses and methods for determing whether cardiopulmonary resuscitation is conducted based on an impedance signal |
US12191030B2 (en) | 2014-07-07 | 2025-01-07 | Zoll Medical Corporation | Medical device with natural language processor |
RU2697374C2 (en) * | 2014-11-25 | 2019-08-13 | Конинклейке Филипс Н.В. | Cardiopulmonary resuscitation assistance system and a cardiopulmonary resuscitation monitoring method |
WO2016100906A1 (en) | 2014-12-18 | 2016-06-23 | Zoll Medical Corporation | Pacing device with acoustic sensor |
WO2016149583A1 (en) | 2015-03-18 | 2016-09-22 | Zoll Medical Corporation | Medical device with acoustic sensor |
WO2016160369A1 (en) | 2015-03-20 | 2016-10-06 | Zoll Medical Corporation | Systems for self-testing an ambulatory medical device |
US10835449B2 (en) | 2015-03-30 | 2020-11-17 | Zoll Medical Corporation | Modular components for medical devices |
US9734720B2 (en) | 2015-04-01 | 2017-08-15 | Zoll Medical Corporation | Response mode verification in vehicle dispatch |
EP3288457B1 (en) * | 2015-04-27 | 2021-09-01 | LifeWatch Technologies Ltd. | Positioning a medical device based on oxygen saturation measurements |
WO2016201367A1 (en) * | 2015-06-11 | 2016-12-15 | Zoll Medical Corporation | Detection of myocardial contractions indicative of perfusion |
CN107809947B (en) * | 2015-06-26 | 2021-08-13 | 皇家飞利浦有限公司 | Determining recovery of spontaneous circulation during CPR |
US10252070B2 (en) | 2015-09-08 | 2019-04-09 | Zoll Medical Corporation | Secure limited components for use with medical devices |
EP3362143B1 (en) | 2015-10-16 | 2023-09-27 | Zoll Medical Corporation | Dual sensor electrodes for providing enhanced resuscitation feedback |
EP3380189B1 (en) | 2015-11-23 | 2020-08-12 | Zoll Medical Corporation | Garments for wearable medical devices |
US11709747B2 (en) | 2016-01-08 | 2023-07-25 | Zoll Medical Corporation | Patient assurance system and method |
JP2017164033A (en) * | 2016-03-14 | 2017-09-21 | 株式会社フジタ医科器械 | Automated external defibrillator |
US11617538B2 (en) | 2016-03-14 | 2023-04-04 | Zoll Medical Corporation | Proximity based processing systems and methods |
US10674911B2 (en) | 2016-03-30 | 2020-06-09 | Zoll Medical Corporation | Systems and methods of integrating ambulatory medical devices |
US10561575B2 (en) * | 2016-03-31 | 2020-02-18 | Zoll Medical Corporation | Monitoring CPR by a wearable medical device |
US10426342B2 (en) | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
US10780020B2 (en) * | 2016-09-30 | 2020-09-22 | Zoll Medical Corporation | Maintaining active compression decompression device adherence |
US10835450B2 (en) * | 2016-12-30 | 2020-11-17 | Stryker Corporation | CPR chest compression system periodically reminding attendant to check patient |
US11523966B2 (en) | 2016-12-30 | 2022-12-13 | Physio-Control, Inc. | CPR chest compression system |
US11213691B2 (en) | 2017-02-27 | 2022-01-04 | Zoll Medical Corporation | Ambulatory medical device interaction |
US11009870B2 (en) | 2017-06-06 | 2021-05-18 | Zoll Medical Corporation | Vehicle compatible ambulatory defibrillator |
EP3417770A1 (en) | 2017-06-23 | 2018-12-26 | Koninklijke Philips N.V. | Device, system and method for detection of pulse and/or pulse-related information of a patient |
US11179293B2 (en) | 2017-07-28 | 2021-11-23 | Stryker Corporation | Patient support system with chest compression system and harness assembly with sensor system |
US10646707B2 (en) | 2017-11-30 | 2020-05-12 | Zoll Medical Corporation | Medical devices with rapid sensor recovery |
US10960213B2 (en) | 2018-03-12 | 2021-03-30 | Zoll Medical Corporation | Verification of cardiac arrhythmia prior to therapeutic stimulation |
US10602945B2 (en) | 2018-03-13 | 2020-03-31 | Zoll Medical Corporation | Telemetry of wearable medical device information to secondary medical device or system |
WO2019178524A1 (en) | 2018-03-16 | 2019-09-19 | Zoll Medical Corporation | Monitoring physiological status based on bio-vibrational and radio frequency data analysis |
WO2019246086A1 (en) | 2018-06-18 | 2019-12-26 | Zoll Medical Corporation | Medical device for estimating risk of patient deterioration |
EP3826539B1 (en) * | 2018-07-26 | 2023-11-01 | Koninklijke Philips N.V. | Device, system and method for detection of pulse of a subject |
CN109044321B (en) * | 2018-08-20 | 2021-01-26 | 温州市人民医院 | System for carrying out medical first aid and emergency monitoring on patient |
WO2020069308A1 (en) | 2018-09-28 | 2020-04-02 | Zoll Medical Corporation | Adhesively coupled wearable medical device |
US11568984B2 (en) | 2018-09-28 | 2023-01-31 | Zoll Medical Corporation | Systems and methods for device inventory management and tracking |
US10918877B2 (en) | 2018-09-28 | 2021-02-16 | Zoll Medical Corporation | Battery lock for ambulatory medical device |
US11918386B2 (en) | 2018-12-26 | 2024-03-05 | Flashback Technologies, Inc. | Device-based maneuver and activity state-based physiologic status monitoring |
US11590354B2 (en) | 2018-12-28 | 2023-02-28 | Zoll Medical Corporation | Wearable medical device response mechanisms and methods of use |
CN112642061A (en) | 2019-10-09 | 2021-04-13 | Zoll医疗公司 | Modular electrotherapy device |
USD926323S1 (en) | 2020-03-30 | 2021-07-27 | Zoll Medical Corporation | Automated external defibrillator electrode pad |
US11938084B2 (en) * | 2020-10-19 | 2024-03-26 | Koninklijke Philips N.V. | External defibrillator pads with visual CPR feedback indicator |
JP7327692B2 (en) * | 2020-12-22 | 2023-08-16 | 株式会社村田製作所 | Sensors, helmets and measurement methods |
Citations (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903873A (en) | 1974-05-13 | 1975-09-09 | Douglas E Royal | Pulse contour measuring instrument |
US4052979A (en) | 1975-12-04 | 1977-10-11 | Mary Ann Scherr | Jewelry and bracelet heartbeat monitor |
US4299233A (en) | 1979-10-03 | 1981-11-10 | Lemelson Jerome H | Patient monitoring device and method |
US4331154A (en) | 1979-10-15 | 1982-05-25 | Tech Engineering & Design | Blood pressure and heart rate measuring watch |
US4443730A (en) | 1978-11-15 | 1984-04-17 | Mitsubishi Petrochemical Co., Ltd. | Biological piezoelectric transducer device for the living body |
US4722347A (en) | 1985-01-15 | 1988-02-02 | Applied Biometrics, Inc. | Apparatus for measuring cardiac output |
US4911167A (en) | 1985-06-07 | 1990-03-27 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4987783A (en) | 1986-02-28 | 1991-01-29 | Antonio Nicholas F D | Sensor and transducer apparatus |
JPH0415038A (en) | 1990-05-10 | 1992-01-20 | Matsushita Electric Ind Co Ltd | Living body monitoring device |
JPH0428344A (en) | 1990-05-25 | 1992-01-30 | Matsushita Electric Ind Co Ltd | On-bed state monitoring device |
JPH0428345A (en) | 1990-05-25 | 1992-01-30 | Matsushita Electric Ind Co Ltd | Living body monitoring device |
US5086776A (en) | 1990-03-06 | 1992-02-11 | Precision Diagnostics, Inc. | Apparatus and method for sensing cardiac performance |
JPH05261071A (en) | 1992-03-19 | 1993-10-12 | Matsushita Electric Ind Co Ltd | On-vehicle heart beat detector |
WO1995006525A1 (en) | 1993-08-30 | 1995-03-09 | Medacoustics, Inc. | Disposable acoustic pad sensors |
US5409009A (en) | 1994-03-18 | 1995-04-25 | Medtronic, Inc. | Methods for measurement of arterial blood flow |
US5431685A (en) | 1992-04-03 | 1995-07-11 | Intermedics, Inc. | Implantable medical interventional device with criteria modification to enhance recognition of Tachycardia |
JPH07265272A (en) | 1994-04-01 | 1995-10-17 | Itec Kk | Nursing/monitoring system |
US5496257A (en) * | 1994-04-22 | 1996-03-05 | Kelly Medical Products, Inc. | Apparatus for assisting in the application of cardiopulmonary resuscitation |
US5588425A (en) | 1993-05-21 | 1996-12-31 | Nims, Incorporated | Method and apparatus for discriminating between valid and artifactual pulse waveforms in pulse oximetry |
US5595188A (en) | 1995-07-26 | 1997-01-21 | Flowscan, Inc. | Assembly process for polymer-based acoustic differential-output sensor |
US5645571A (en) | 1995-08-01 | 1997-07-08 | Survivalink Corporation | Automated external defibrillator with lid activated self-test system |
JPH1026716A (en) | 1996-07-12 | 1998-01-27 | Mitsubishi Electric Corp | Optical beam shape measuring method for light emitting module |
WO1998026716A1 (en) | 1996-12-18 | 1998-06-25 | Sailor Mohler | Piezoelectric sensor for blood pressure measurement |
US5795300A (en) | 1994-06-01 | 1998-08-18 | Advanced Body Metrics Corporation | Heart pulse monitor |
US5807267A (en) | 1994-06-01 | 1998-09-15 | Advanced Body Metrics Corporation | Heart pulse monitor |
US5807268A (en) | 1992-09-09 | 1998-09-15 | Medacoustics, Inc. | Disposable sensing device with contaneous conformance |
US5827198A (en) | 1996-11-21 | 1998-10-27 | Flowscan, Inc. | Low-cost, disposable, polymer-based, differential output flexure sensor and method of fabricating same |
US5991661A (en) | 1997-10-17 | 1999-11-23 | Pacesetter, Inc. | System and method for measuring cardiac activity |
WO2001022885A1 (en) | 1999-09-30 | 2001-04-05 | Medtronic Physio-Control Manufacturing Corp. | Method and apparatus for using heart sounds to determine the presence of a pulse |
US6298267B1 (en) | 1999-04-30 | 2001-10-02 | Intermedics Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6304773B1 (en) | 1998-05-21 | 2001-10-16 | Medtronic Physio-Control Manufacturing Corp. | Automatic detection and reporting of cardiac asystole |
US20010047140A1 (en) | 2000-02-04 | 2001-11-29 | Freeman Gary A. | Integrated resuscitation |
US6356785B1 (en) | 1997-11-06 | 2002-03-12 | Cecily Anne Snyder | External defibrillator with CPR prompts and ACLS prompts and methods of use |
US20020165585A1 (en) | 2001-05-01 | 2002-11-07 | Dupelle Michael R. | Pulse sensors |
US20020173725A1 (en) | 2001-05-18 | 2002-11-21 | Rock Joseph E. | Integrated cardiac resuscitation system with ability to detect perfusion |
US6487442B1 (en) | 2000-04-28 | 2002-11-26 | Nicholas Wood | Detection of abnormal and induction of normal heat rate variability |
US6567697B1 (en) | 1994-05-31 | 2003-05-20 | Galvani, Ltd. | External defibrillator with electrical CPR assist |
US20040039420A1 (en) | 2002-08-26 | 2004-02-26 | Medtronic Physio-Control Manufacturing Corp. | Apparatus, software, and methods for cardiac pulse detection using accelerometer data |
JP4015038B2 (en) | 2003-02-14 | 2007-11-28 | 古河電気工業株式会社 | Flat cable connection terminal and connection part of flat cable and connection terminal |
JP4028344B2 (en) | 2001-10-19 | 2007-12-26 | ホシザキ電機株式会社 | Storage |
JP4028345B2 (en) | 2002-10-16 | 2007-12-26 | 古河電気工業株式会社 | Design method of flat conductor for flat cable and flat cable |
USRE44187E1 (en) * | 2003-04-23 | 2013-04-30 | Zoll Medical Corporation | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
JP5261071B2 (en) | 2008-08-20 | 2013-08-14 | 浜松ホトニクス株式会社 | Observation apparatus and observation method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6591135B2 (en) * | 2001-04-16 | 2003-07-08 | Ge Medical Systems Information Technologies, Inc. | Portable patient monitor with defibrillator/pacemaker interface and battery power management |
-
2003
- 2003-05-20 US US10/441,933 patent/US20040215244A1/en not_active Abandoned
-
2004
- 2004-04-20 WO PCT/US2004/012104 patent/WO2004093651A2/en active Application Filing
- 2004-10-05 US US10/958,953 patent/US20050043763A1/en not_active Abandoned
-
2005
- 2005-09-15 US US11/228,857 patent/US7488293B2/en not_active Ceased
-
2011
- 2011-02-10 US US13/025,124 patent/USRE44187E1/en not_active Expired - Fee Related
-
2013
- 2013-04-26 US US13/872,037 patent/USRE45922E1/en not_active Expired - Lifetime
Patent Citations (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903873A (en) | 1974-05-13 | 1975-09-09 | Douglas E Royal | Pulse contour measuring instrument |
US4052979A (en) | 1975-12-04 | 1977-10-11 | Mary Ann Scherr | Jewelry and bracelet heartbeat monitor |
US4443730A (en) | 1978-11-15 | 1984-04-17 | Mitsubishi Petrochemical Co., Ltd. | Biological piezoelectric transducer device for the living body |
US4299233A (en) | 1979-10-03 | 1981-11-10 | Lemelson Jerome H | Patient monitoring device and method |
US4331154A (en) | 1979-10-15 | 1982-05-25 | Tech Engineering & Design | Blood pressure and heart rate measuring watch |
US4722347A (en) | 1985-01-15 | 1988-02-02 | Applied Biometrics, Inc. | Apparatus for measuring cardiac output |
US4911167A (en) | 1985-06-07 | 1990-03-27 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
US4987783A (en) | 1986-02-28 | 1991-01-29 | Antonio Nicholas F D | Sensor and transducer apparatus |
US5086776A (en) | 1990-03-06 | 1992-02-11 | Precision Diagnostics, Inc. | Apparatus and method for sensing cardiac performance |
JPH0415038A (en) | 1990-05-10 | 1992-01-20 | Matsushita Electric Ind Co Ltd | Living body monitoring device |
JPH0428345A (en) | 1990-05-25 | 1992-01-30 | Matsushita Electric Ind Co Ltd | Living body monitoring device |
JPH0428344A (en) | 1990-05-25 | 1992-01-30 | Matsushita Electric Ind Co Ltd | On-bed state monitoring device |
JPH05261071A (en) | 1992-03-19 | 1993-10-12 | Matsushita Electric Ind Co Ltd | On-vehicle heart beat detector |
US5431685A (en) | 1992-04-03 | 1995-07-11 | Intermedics, Inc. | Implantable medical interventional device with criteria modification to enhance recognition of Tachycardia |
US5913829A (en) | 1992-09-09 | 1999-06-22 | Medacoustics, Inc. | Sensing device for acoustic energy |
US5807268A (en) | 1992-09-09 | 1998-09-15 | Medacoustics, Inc. | Disposable sensing device with contaneous conformance |
US5588425A (en) | 1993-05-21 | 1996-12-31 | Nims, Incorporated | Method and apparatus for discriminating between valid and artifactual pulse waveforms in pulse oximetry |
WO1995006525A1 (en) | 1993-08-30 | 1995-03-09 | Medacoustics, Inc. | Disposable acoustic pad sensors |
US5885222A (en) | 1993-08-30 | 1999-03-23 | Medacoustics, Inc. | Disposable acoustic pad sensors |
US5409009A (en) | 1994-03-18 | 1995-04-25 | Medtronic, Inc. | Methods for measurement of arterial blood flow |
JPH07265272A (en) | 1994-04-01 | 1995-10-17 | Itec Kk | Nursing/monitoring system |
US5496257A (en) * | 1994-04-22 | 1996-03-05 | Kelly Medical Products, Inc. | Apparatus for assisting in the application of cardiopulmonary resuscitation |
US6567697B1 (en) | 1994-05-31 | 2003-05-20 | Galvani, Ltd. | External defibrillator with electrical CPR assist |
US5807267A (en) | 1994-06-01 | 1998-09-15 | Advanced Body Metrics Corporation | Heart pulse monitor |
US5795300A (en) | 1994-06-01 | 1998-08-18 | Advanced Body Metrics Corporation | Heart pulse monitor |
US5595188A (en) | 1995-07-26 | 1997-01-21 | Flowscan, Inc. | Assembly process for polymer-based acoustic differential-output sensor |
US5645571A (en) | 1995-08-01 | 1997-07-08 | Survivalink Corporation | Automated external defibrillator with lid activated self-test system |
US5645571B1 (en) | 1995-08-01 | 1999-08-24 | Surviva Link Corp | Automated external defibrillator with lid activated self-test system |
JPH1026716A (en) | 1996-07-12 | 1998-01-27 | Mitsubishi Electric Corp | Optical beam shape measuring method for light emitting module |
US5827198A (en) | 1996-11-21 | 1998-10-27 | Flowscan, Inc. | Low-cost, disposable, polymer-based, differential output flexure sensor and method of fabricating same |
WO1998026716A1 (en) | 1996-12-18 | 1998-06-25 | Sailor Mohler | Piezoelectric sensor for blood pressure measurement |
US5991661A (en) | 1997-10-17 | 1999-11-23 | Pacesetter, Inc. | System and method for measuring cardiac activity |
US6356785B1 (en) | 1997-11-06 | 2002-03-12 | Cecily Anne Snyder | External defibrillator with CPR prompts and ACLS prompts and methods of use |
US6304773B1 (en) | 1998-05-21 | 2001-10-16 | Medtronic Physio-Control Manufacturing Corp. | Automatic detection and reporting of cardiac asystole |
US6298267B1 (en) | 1999-04-30 | 2001-10-02 | Intermedics Inc. | Method and apparatus for treatment of cardiac electromechanical dissociation |
US6440082B1 (en) | 1999-09-30 | 2002-08-27 | Medtronic Physio-Control Manufacturing Corp. | Method and apparatus for using heart sounds to determine the presence of a pulse |
WO2001022885A1 (en) | 1999-09-30 | 2001-04-05 | Medtronic Physio-Control Manufacturing Corp. | Method and apparatus for using heart sounds to determine the presence of a pulse |
US20030060723A1 (en) | 1999-09-30 | 2003-03-27 | Medtronic Physio-Control Manufacturing Corp. | Pulse detection apparatus, software, and methods using patient physiological signals |
US20010047140A1 (en) | 2000-02-04 | 2001-11-29 | Freeman Gary A. | Integrated resuscitation |
US6487442B1 (en) | 2000-04-28 | 2002-11-26 | Nicholas Wood | Detection of abnormal and induction of normal heat rate variability |
US20020165585A1 (en) | 2001-05-01 | 2002-11-07 | Dupelle Michael R. | Pulse sensors |
US6575914B2 (en) | 2001-05-18 | 2003-06-10 | Koninklijke Philips Electronics N.V. | Integrated cardiac resuscitation system with ability to detect perfusion |
US20020173725A1 (en) | 2001-05-18 | 2002-11-21 | Rock Joseph E. | Integrated cardiac resuscitation system with ability to detect perfusion |
JP4028344B2 (en) | 2001-10-19 | 2007-12-26 | ホシザキ電機株式会社 | Storage |
US20040039420A1 (en) | 2002-08-26 | 2004-02-26 | Medtronic Physio-Control Manufacturing Corp. | Apparatus, software, and methods for cardiac pulse detection using accelerometer data |
JP4028345B2 (en) | 2002-10-16 | 2007-12-26 | 古河電気工業株式会社 | Design method of flat conductor for flat cable and flat cable |
JP4015038B2 (en) | 2003-02-14 | 2007-11-28 | 古河電気工業株式会社 | Flat cable connection terminal and connection part of flat cable and connection terminal |
USRE44187E1 (en) * | 2003-04-23 | 2013-04-30 | Zoll Medical Corporation | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation |
JP5261071B2 (en) | 2008-08-20 | 2013-08-14 | 浜松ホトニクス株式会社 | Observation apparatus and observation method |
Non-Patent Citations (2)
Title |
---|
Kassal et al., "Polymer-Based Adherent Differential-Output Sensor for Cardiac Auscultation," Medical Electronics, vol. 25, No. 4, Issue 148, pp. 54-63 (Sep. 1994). |
Webster, John G., Medical Instrumentation, Application and Design, 3rd ed., New York, NY, John J. Wiley & Sons, Inc. 1998. |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10542961B2 (en) | 2015-06-15 | 2020-01-28 | The Research Foundation For The State University Of New York | System and method for infrasonic cardiac monitoring |
US11478215B2 (en) | 2015-06-15 | 2022-10-25 | The Research Foundation for the State University o | System and method for infrasonic cardiac monitoring |
US20180055382A1 (en) * | 2016-08-23 | 2018-03-01 | Covidien Lp | Automatic estimation of pulse deficit |
US10463261B2 (en) * | 2016-08-23 | 2019-11-05 | Covidien Lp | Automatic estimation of pulse deficit |
WO2018165634A1 (en) * | 2017-03-09 | 2018-09-13 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems, devices, and methods for monitoring and modulation of therapeutic procedures |
US11298290B2 (en) | 2017-03-09 | 2022-04-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems, devices, and methods for monitoring and modulation of therapeutic procedures |
Also Published As
Publication number | Publication date |
---|---|
US20050043763A1 (en) | 2005-02-24 |
WO2004093651A2 (en) | 2004-11-04 |
US20060009809A1 (en) | 2006-01-12 |
USRE44187E1 (en) | 2013-04-30 |
WO2004093651A3 (en) | 2005-02-03 |
US7488293B2 (en) | 2009-02-10 |
US20040215244A1 (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE45922E1 (en) | Processing pulse signal in conjunction with accelerometer signal in cardiac resuscitation | |
US5957856A (en) | Method and system for predicting the immediate success of a defibrillatory shock during cardiac arrest | |
US9981142B2 (en) | Pulse detection apparatus, software, and methods using patient physiological signals | |
JP5103482B2 (en) | Heart attack detector | |
US7366569B2 (en) | Non-invasive method and apparatus for cardiac pacemaker pacing parameter optimization and monitoring of cardiac dysfunction | |
JP7319995B2 (en) | Apparatus, system and method for supporting detection of spontaneous recirculation during cardiopulmonary resuscitation | |
JP6034539B1 (en) | Decision to resume self-beat during CPR | |
US10675213B2 (en) | Determining return of spontaneous circulation during CPR | |
US8764674B2 (en) | Heart sound monitoring of pulmonary hypertension | |
US10596064B2 (en) | CPR chest compression system with tonometric input and feedback | |
US20080215102A1 (en) | Method and system aiding decision making during CPR | |
US20190374428A1 (en) | Systems and methods of synchronizing chest compressions with myocardial activity | |
JP6979053B2 (en) | Devices and methods for detecting ventricular fibrillation | |
US20230149258A1 (en) | Selective activation of chest compressions synchronized with myocardial activity | |
Jang et al. | Analysis of relation between coronary perfusion pressure and the extracted parameters from a ventricular fibrillation ECG signal |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Fee payment |
Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |